[Hypertrophic cardiomyopathy with restrictive pathophysiology: is there a role for cardiopulmonary exercise testing?]

G Ital Cardiol (Rome). 2012 Dec;13(12):861; author's reply p.861. doi: 10.1714/1188.13171.
[Article in Italian]
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acetanilides / therapeutic use*
  • Cardiomyopathy, Hypertrophic / drug therapy*
  • Cardiomyopathy, Hypertrophic / physiopathology*
  • Cardiomyopathy, Restrictive / drug therapy*
  • Cardiomyopathy, Restrictive / physiopathology*
  • Cardiovascular Agents / therapeutic use*
  • Enzyme Inhibitors / therapeutic use*
  • Female
  • Humans
  • Piperazines / therapeutic use*

Substances

  • Acetanilides
  • Cardiovascular Agents
  • Enzyme Inhibitors
  • Piperazines